Similarly, Yeo et al. reported that Parkin expression was dramatically reduced in glioma cells, while the restoration of its expression promoted G1 phase cell-cycle arrest and mitigated the cell proliferation rate both in vitro and in vivo [41]. The gene discussed is PRKN; the disease is central nervous system cancer.